Stockscreener 앱 받기
8.00
1.24%
-0.05
Elicio Therapeutics Inc 주식(ELTX)의 최신 뉴스
Elicio Therapeutics Secures Strategic Financing As Pivotal Cancer Trial Data Approaches - Barchart.com
Elicio Therapeutics to Host Virtual KOL Event on June 25, - GlobeNewswire
Elicio Therapeutics to Host Virtual KOL Event on June 25, 2025 to Discuss AMP-Powered ELI-002 for the Treatment of KRAS mutation-driven Pancreatic Cancer - GlobeNewswire Inc.
Elicio secures $10 million to extend cash runway By Investing.com - Investing.com South Africa
Elicio Therapeutics Secures $10 Million in Financing - citybiz
Elicio Therapeutics Gets $10 Million Note Financing - marketscreener.com
Elicio secures $10 million to extend cash runway - Investing.com
Elicio Therapeutics Secures $10M Financing for Operations - TipRanks
Elicio Therapeutics (ELTX) Secures $10M Financing to Extend Operations | ELTX Stock News - GuruFocus
Elicio Therapeutics Lands $10M Funding to Advance Revolutionary Cancer Vaccine Through Critical Trial Phase - Stock Titan
When the Price of (ELTX) Talks, People Listen - news.stocktradersdaily.com
Elicio Therapeutics announces board election results By Investing.com - Investing.com Nigeria
Elicio Therapeutics Elects New Directors at Annual Meeting - TipRanks
Elicio Therapeutics announces board election results - Investing.com
Elicio Therapeutics Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Elicio's (ELTX) ELI-002 Interim Analysis Anticipated in Phase 2 Trial | ELTX Stock News - GuruFocus
Elicio Therapeutics: Q1 Earnings Snapshot - CTPost
Elicio Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Updates - GlobeNewswire
Learn to Evaluate (ELTX) using the Charts - news.stocktradersdaily.com
Here's Why Elicio Therapeutics (ELTX) Could be Great Choice for a Bottom Fisher - Yahoo Finance
Long Term Trading Analysis for (ELTX) - news.stocktradersdaily.com
Elicio Therapeutics Reports Inducement Grant to New Chief Strategy and Financial Officer and Other New Hires - GlobeNewswire
Key Executive Appointment: Elicio Therapeutics Names New Chief Strategy and Financial Officer - Stock Titan
Elicio Therapeutics grants inducement award to new chief strategy and financial officer - MSN
(ELTX) Investment Report - news.stocktradersdaily.com
Elicio Therapeutics (ELTX) Upgraded to Buy: Here's What You Should Know - MSN
Is Elicio Therapeutics, Inc. (ELTX) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Earnings Preview: What To Expect From Johnson & Johnson's Report - Barchart.com
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Elicio Therapeutics Advances Cancer Immunotherapy Pipeline - TipRanks
Elicio signals delay in mid-stage cancer vaccine study; shares slump - TradingView
Elicio Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Elicio Therapeutics, Inc. SEC 10-K Report - TradingView
Elicio Therapeutics Reports 2024 Financial Results and Provides Corporate Updates - GlobeNewswire
Elicio's Latest Financial Results Reveal Key Clinical Milestones and 28.9-Month Survival Data - Stock Titan
(ELTX) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com
ELICIO THERAPEUTICS Earnings Preview: Recent $ELTX Insider Trading, Hedge Fund Activity, and More - Nasdaq
Elicio Therapeutics Names Preetam Shah CFO -March 24, 2025 at 08:17 am EDT - MarketScreener
Elicio Therapeutics Appoints Preetam Shah, Ph.D., MBA, as Chief Strategy and Financial Officer - GlobeNewswire
Elicio Therapeutics Hires CFO From Cidara Therapeutics - MarketWatch
Elicio Therapeutics Appoints New Chief Strategy and Financial Officer - TipRanks
Elicio Therapeutics appoints new CSFO amid clinical trials - Investing.com
Strategic Move: Elicio Strengthens Leadership Team Ahead of Crucial Phase 2 Trial Results - Stock Titan
Elicio Therapeutics, Inc. (NASDAQ:ELTX) surges 13%; individual investors who own 49% shares profited along with insiders - simplywall.st
0.66%
1.05%
자본화:
|
볼륨(24시간):